Release Date: 24/07/13 08:29 Summary: Atlas June 2013 Quarterly Activities Report Price Sensitive: Yes Download Document 2.61MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%